213 related articles for article (PubMed ID: 32501031)
1. Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane.
Scheibe A; Shelly S; Hugo J; Mohale M; Lalla S; Renkin W; Gloeck N; Khambule S; Kroukamp L; Bhoora U; Marcus TS
Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e6. PubMed ID: 32501031
[TBL] [Abstract][Full Text] [Related]
2. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
Goeieman DS; Nonyane DS; Nzaumvila DK; Anse van Rensburg MNS
Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e10. PubMed ID: 36744456
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction in an emergency response to homelessness during South Africa's COVID-19 lockdown.
Marcus TS; Heese J; Scheibe A; Shelly S; Lalla SX; Hugo JF
Harm Reduct J; 2020 Aug; 17(1):60. PubMed ID: 32831083
[TBL] [Abstract][Full Text] [Related]
4. 'I went for rehab many times and it never worked, but the harm reduction process has given me renewed hope'. Perceptions on the effectiveness of harm reduction and community-based opioid substitution therapy.
Nyashanu T; Scheibe A; Visser M
Health Promot J Austr; 2023 Aug; ():. PubMed ID: 37605794
[TBL] [Abstract][Full Text] [Related]
5. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
[TBL] [Abstract][Full Text] [Related]
6. A plea of those who are affected most by HIV: The utterances by women who inject Nyaope residing in the City of Tshwane Municipality, Gauteng.
Lefoka MH; Netangaheni TR
Afr J Prim Health Care Fam Med; 2021 Aug; 13(1):e1-e9. PubMed ID: 34476973
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and characteristics of moderate- to high-risk regulated and unregulated substance use among patients admitted to four public hospitals in Tshwane, South Africa.
Scheibe AP; Gloeck NR; Shelly S; Marcus TS; Hugo J
S Afr Med J; 2019 Nov; 109(12):971-977. PubMed ID: 31865961
[TBL] [Abstract][Full Text] [Related]
8. HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service.
Torres-Leguizamon M; Reynaud EG; Néfau T; Duplessy C
Harm Reduct J; 2020 Aug; 17(1):59. PubMed ID: 32831094
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a community-based buprenorphine treatment intervention.
Fox AD; Sohler NL; Frost T; Lopez C; Cunningham CO
Harm Reduct J; 2017 May; 14(1):23. PubMed ID: 28499432
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
Goeieman DS; Nonyane DS; Nzaumvila DK; Janse van Rensburg MNS
Afr J Prim Health Care Fam Med; 2023 Nov; 15(1):4033. PubMed ID: 38044893
[TBL] [Abstract][Full Text] [Related]
11. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
Bonny-Noach H
Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
[TBL] [Abstract][Full Text] [Related]
12. Harm reduction for drug abusing ex-offenders: outcome of the California prevention and education project MORE project.
Bowser BP; Jenkins-Barnes T; Dillard-Smith C; Lockett G
J Evid Based Soc Work; 2010 Jan; 7(1):15-29. PubMed ID: 20178022
[TBL] [Abstract][Full Text] [Related]
13. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
[TBL] [Abstract][Full Text] [Related]
14. Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015.
Wild TC; Pauly B; Belle-Isle L; Cavalieri W; Elliott R; Strike C; Tupper K; Hathaway A; Dell C; MacPherson D; Sinclair C; Karekezi K; Tan B; Hyshka E
Int J Drug Policy; 2017 Jul; 45():9-17. PubMed ID: 28454045
[TBL] [Abstract][Full Text] [Related]
15. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
16. A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study.
Kapadia SN; Griffin JL; Waldman J; Ziebarth NR; Schackman BR; Behrends CN
J Gen Intern Med; 2021 Jul; 36(7):1898-1905. PubMed ID: 33469774
[TBL] [Abstract][Full Text] [Related]
17. Harm reduction: a public health approach to prison drug use.
Belisle LA; Solano-Patricio EDC
Int J Prison Health; 2021 Dec; ():. PubMed ID: 34962726
[TBL] [Abstract][Full Text] [Related]
18. A national public health programme on gambling policy development in New Zealand: insights from a process evaluation.
Kolandai-Matchett K; Landon J; Bellringer M; Abbott M
Harm Reduct J; 2018 Mar; 15(1):11. PubMed ID: 29510708
[TBL] [Abstract][Full Text] [Related]
19. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
Ashford RD; Curtis B; Brown AM
Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
[TBL] [Abstract][Full Text] [Related]
20. Harm Reduction: Front Line Public Health.
Stancliff S; Phillips BW; Maghsoudi N; Joseph H
J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
